Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't ...

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the ...

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...

In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.9 billion and currently trading near ...

Wells Fargo has recently reduced T-Mobile Us Inc (TMUS) stock to Equal Weight rating, as announced on January 6, 2025, according to Finviz. Earlier, on January 6, 2025, RBC Capital Mkts had reduced ...

Morgan Stanley will work with the U.S. Treasury and other regulators to figure out how it can offer crypto in a safe way ...

RBC BlueBay Asset Management’s hedge fund is seeing an opportunity to profit from volatility during US President Donald Trump’s second term, after outperforming the industry in a difficult period for ...

The round, which values Databricks at $US62 billion, was led by Temasek, Macquarie Capital and Qatar’s sovereign wealth fund ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...